Effect of stress on hepatic 11β-hydroxysteroid dehydrogenase activity and its influence on carbohydrate metabolism

Author： Altuna María E. Lelli Sandra Marcela Martín de Viale Leonor C. San Damasco María Cristina

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.84, Iss.10, 2006-10, pp. : 977-984

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents

By Webster Scott Peter Pallin Thomas David

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 12, 2007-12 ,pp. : 1407-1422

Informa Healthcare

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases

By Fotsch Christopher Askew Ben C Chen Jian Jeffrey

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 289-303

Informa Healthcare

Access to resources Recommend Favorite

Adrenal 11-beta hydroxysteroid dehydrogenase activity in response to stress

By Zallocchi Marisa Matkovic Laura Damasco María C

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 6, 2004-05 ,pp. : 422-425

NRC Research Press

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease

By Walker Brian R Seckl Jonathan R

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 6, 2003-12 ,pp. : 771-783

Informa Healthcare

Access to resources Recommend Favorite

Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome – 11β-hydroxysteroid dehydrogenase type 1

By Stewart Paul M

Clinical Medicine, Vol. 5, Iss. 2, 2005-03 ,pp. : 142-146

Royal College Of Physicians

Access to resources Recommend Favorite